Status:
UNKNOWN
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Follicular Lymphoma (FL)
Mantle Cell Lymphoma (MCL)
Eligibility:
All Genders
18+ years
Brief Summary
To determine whether peripheral blood flow cytometry can reduce or replace invasive bone marrow examinations in patients with slow growing lymphomas.
Detailed Description
This study will determine whether peripheral blood flow cytometry can reduce or replace invasive bone marrow examinations in patients with slow growing lymphomas. Patients with certain types of slow ...
Eligibility Criteria
Inclusion
- Individuals ≥18yrs of age
- Able to provide informed written consent
- Patients with a diagnosis of follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma requiring staging or re-staging as part of clinical management
- pre-transplant bone marrow assessment
- High grade transformation associated with the above lymphomas will be allowed.
Exclusion
- Patients with a histological diagnosis other than those mentioned above or those diagnosed with 2 or more different lymphomas, excluding transformed lymphoma.
- Patients not fit enough to undergo bone marrow examination.
Key Trial Info
Start Date :
July 19 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03265158
Start Date
July 19 2017
End Date
April 1 2020
Last Update
August 29 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Marsden NHS Foundation Trust
London, Surrey, United Kingdom, SW3 6JJ
2
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT